***CLOSING DATE EXTENDED UNTIL DEC 31st 2020***
Take the IMPACT ALS European survey before December 31st to help guide drug development and services for amyotrophic lateral sclerosis (ALS)/motor neurone disease (MND). In an effort to include your perspective to help guide the development of new drugs and services for ALS/MND, we are conducting a survey of patients with ALS/MND and of current and former caregivers. This initiative, titled IMPACT-ALS (Investigating and Measuring Patient and Caregiver Trends about ALS), is a research collaboration between industry, European ALS doctors and ALS charities. Thanks to all those who have taken the survey so far- your opinion matters to us!!
Please access this important survey by clicking here
More information can be found here: impact-als-eu-survey-flyer_ireland